Cubist Systematic Strategies’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,393
Closed -$95K 2062
2016
Q4
$95K Buy
3,393
+3,293
+3,293% +$92.2K 0.01% 1498
2016
Q3
$3K Buy
+100
New +$3K ﹤0.01% 1665
2016
Q2
Sell
-14,412
Closed -$322K 2052
2016
Q1
$322K Buy
+14,412
New +$322K 0.02% 947
2015
Q4
Sell
-8,973
Closed -$232K 2189
2015
Q3
$232K Buy
+8,973
New +$232K 0.01% 1391
2015
Q2
Sell
-9,391
Closed -$237K 2302
2015
Q1
$237K Sell
9,391
-22,680
-71% -$572K 0.01% 1417
2014
Q4
$752K Buy
32,071
+6,536
+26% +$153K 0.04% 651
2014
Q3
$581K Buy
+25,535
New +$581K 0.04% 739

Other funds holding QGENF

Cubist Systematic Strategies's QGENF Position: Q1 2017 in Review

Cubist Systematic Strategies sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 3,393 shares — an estimated $95K sold.

Cubist Systematic Strategies first reported a position in QGENF in Q3 2014 and held it in 7 quarters. The position peaked at $752K in Q4 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Cubist Systematic Strategies reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Cubist Systematic Strategies sold 3,393 QIAGEN NV shares in Q1 2017, an estimated $95K.
  • Cubist Systematic Strategies first reported a position in QIAGEN NV in Q3 2014 and held it in 7 quarters.
  • Cubist Systematic Strategies's QIAGEN NV position peaked at $752K in Q4 2014.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Cubist Systematic Strategies's 13F filing for Q1 2017, filed 15 May 2017.